KURA

Neutral

Number of shareholders of Kura Oncology, Inc. – NASDAQ:KURA

This article provides details on Kura Oncology, Inc. (NASDAQ: KURA), focusing on its number of shareholders. It lists various financial data sources a...

TradingView 3 days ago 0

Bullish

Kura Oncology reports tumor shrinkage in cancer drug trial By Investing.com

Kura Oncology announced positive results from its FIT-001 clinical trial for darlifarnib combined with adagrasib in treating KRAS G12C-mutated advance...

Investing.com Canada 2 weeks ago 0

Bullish

Kura Oncology Reports Strong Clinical Activity and Safety with Darlifarnib + Adagrasib in KRAS G12C-Mutated Solid Tumors

Kura Oncology reported compelling first-in-human data from the FIT-001 clinical trial, showing strong clinical activity and a manageable safety profil...

GlobeNewswire 2 weeks ago 0

Bullish

Experimental drug combo shrinks tumors in 77% of advanced cancer patients

Kura Oncology reported positive Phase 1a clinical trial data for its darlifarnib and adagrasib combination therapy in KRAS G12C-mutated advanced solid...

Stock Titan 2 weeks ago 0